Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation
Cancer Cell · 2023-12 · 41 (12) · 2066-2082.e9
DOI: 10.1016/j.ccell.2023.10.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2023-12. Verfasst von Chia-Chun Chen und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Medical Pharmacology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Small Cell, Prostatic Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Parker Institute for Cancer Immunotherapy.
Abstract (Originalsprache)
Trans-differentiation from an adenocarcinoma to a small cell neuroendocrine state is associated with therapy resistance in multiple cancer types. To gain insight into the underlying molecular events of the trans-differentiation, we perform a multi-omics time course analysis of a pan-small cell neuroendocrine cancer model (termed PARCB), a forward genetic transformation using human prostate basal cells and identify a shared developmental, arc-like, and entropy-high trajectory among all transformation model replicates. Further mapping with single cell resolution reveals two distinct lineages defined by mutually exclusive expression of ASCL1 or ASCL2. Temporal regulation by groups of transcription factors across developmental stages reveals that cellular reprogramming precedes the induction of neuronal programs. TFAP4 and ASCL1/2 feedback are identified as potential regulators of ASCL1 and ASCL2 expression. Our study provides temporal transcriptional patterns and uncovers pan-tissue parallels between prostate and lung cancers, as well as connections to normal neuroendocrine cell states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Medical Pharmacology, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
- Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA.
- Department of Bioengineering, UCLA, Los Angeles, CA, USA.
- Eli and Edythe Broad Stem Cell Research Center, UCLA, Los Angeles, CA, USA.
- Department of Biological Chemistry, UCLA, Los Angeles, CA, USA.
- Department of Urology, University of Washington School of Medicine, Seattle, WA, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- Parker Institute for Cancer Immunotherapy
- NIH
- University of California, Los Angeles
- U.S. Department of Defense
- Institute for Prostate Cancer Research
- National Institute of General Medical Sciences
Zitieren
APA
Chen, C. C., Tran, W., Song, K., Sugimoto, T., Obusan, M. B., Wang, L., Sheu, K. M., Cheng, D., Ta, L., Varuzhanyan, G., Huang, A., Xu, R., Zeng, Y., Borujerdpur, A., Bayley, N. A., Noguchi, M., Mao, Z., Morrissey, C., Corey, E., …, & Graeber, T. G. (2023). Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation. Cancer Cell, 41(12), 2066-2082.e9. https://doi.org/10.1016/j.ccell.2023.10.009
Vancouver
Chen CC, Tran W, Song K, Sugimoto T, Obusan MB, Wang L, et al. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation. Cancer Cell. 2023;41(12):2066-2082.e9. doi:10.1016/j.ccell.2023.10.009
BibTeX
@article{Chen2023,
author = {Chen, Chia-Chun and Tran, Wendy and Song, Kai and Sugimoto, Tyler and Obusan, Matthew B and Wang, Liang and Sheu, Katherine M and Cheng, Donghui and Ta, Lisa and Varuzhanyan, Grigor and Huang, Arthur and Xu, Runzhe and Zeng, Yuanhong and Borujerdpur, Amirreza and Bayley, Nicholas A and Noguchi, Miyako and Mao, Zhiyuan and Morrissey, Colm and Corey, Eva and Nelson, Peter S and Zhao, Yue and Huang, Jiaoti and Park, Jung Wook and Witte, Owen N and Graeber, Thomas G},
title = {Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {12},
pages = {2066--2082.e9},
doi = {10.1016/j.ccell.2023.10.009}
}
EUVIMED